Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in people with type 1 diabetes, regardless of body mass index (BMI ...

Long-term weight stability is recommended to improve health outcomes in individuals with type 1 diabetes. Chronic kidney disease has been linked to yo-yo dieting (also known as body-weight cycling ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to ... to reduce certain risks associated with chronic kidney disease, drugmaker Novo Nordisk said Tuesday. A Phase 3 clinical ...

Acid reflux, or gastroesophageal reflux (GERD), is a common condition that happens when stomach acid flows back up into the esophagus, causing discomfort such as heartburn. It can be triggered by ...

inflammation between the kidney tubules and drug-induced pancreatitis, the study noted. Related FDA approves weight-loss drug Zepbound to treat sleep apnea FDA says shortage of GLP-1 drug ...